US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 1.920
  • -0.030-1.54%
Close Apr 26 16:00 ET
  • 1.900
  • -0.020-1.04%
Post 19:59 ET
100.59MMarket Cap-129P/E (TTM)

About Emergent BioSolutions Company

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Company Profile

SymbolEBS
Company NameEmergent BioSolutions
Listing DateOct 2, 2009
Issue Price12.50
Founded1998
CEOMr. Joseph C. Papa
MarketNYSE
Employees1600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address300 Professional Drive,Suite 400
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-631-3200
Websitehttp://www.emergentbiosolutions.com

Company Executives

  • Name
  • Position
  • Salary
  • Joseph C. Papa
  • Director, President and Chief Executive Officer
  • --
  • Richard S. Lindahl
  • Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
  • 2.18M
  • Coleen Glessner
  • Executive Vice President, Quality and Ethics and Compliance
  • 1.68M
  • Paul Williams
  • Senior Vice President, Products Business
  • 1.06M
  • Jennifer Fox
  • Executive Vice President, External Affairs, General Counsel and Secretary
  • 2.13M
  • Dr. Zsolt Harsanyi,PhD
  • Chairman of The Board
  • 535.98K
  • Sujata Dayal
  • Director
  • 382.23K
  • Keith A. Katkin
  • Independent Director
  • 396.99K
  • Dr. Kathryn C. Zoon, PhD
  • Independent Director
  • 413.48K
  • Marvin L. White
  • Independent Director
  • 405.98K
  • General George A. Joulwan
  • Independent Director
  • 41.83K
  • Donald W. DeGolyer
  • Independent Director
  • 397.50K
  • Ronald B. Richard
  • Independent Director
  • 394.73K
  • Dr. Louis W. Sullivan, M.D.
  • Independent Director
  • 400.23K
  • Neal F. Fowler
  • Independent Director
  • 398.75K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg